Justice Department withdraws legal motion against Ranbaxy

10/9/2008 | Financial Times (free content)

The U.S. Department of Justice said it is no longer pursuing legal action against Ranbaxy Laboratories after the generic-drug firm submitted documents for an inquiry into alleged production violations at two of its facilities in India. An FDA ban on some of Ranbaxy's products remains in effect despite the department's move.

View Full Article in:

Financial Times (free content)

Published in Brief:

SmartBrief Job Listings for Health Care